Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TIM3 Signaling in Effector T Cells Acts as an Immunometabolic Switch in the Purine Degradation Pathway to Suppress Intestinal Inflammation.

Gastroenterology·2026
Same author

Author Correction: Regulatory T cells in the mouse hypothalamus control immune activation and ameliorate metabolic impairments in high-calorie environments.

Nature communications·2026
Same author

Targeting the transcription factor GATA3 by the DNAzyme formulation SB012 in patients with moderately-to-severely active ulcerative colitis: a multicenter, randomized, placebo-controlled, phase 2a induction trial.

Inflammatory bowel diseases·2026
Same author

Early Gut-Vascular Barrier Breakdown Precedes Colitis Onset in Murine Models.

Cellular and molecular gastroenterology and hepatology·2026
Same author

Interaction of nanodrug delivery systems via fibroblasts in colorectal cancer.

Expert opinion on drug delivery·2025
Same author

Quercetin-Loaded Nanoparticles: A Promising Therapeutic Strategy for Inflammatory Bowel Disease.

Journal of inflammation research·2025

Related Experiment Video

Updated: Mar 15, 2026

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

2.1K

Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.

Vanessa Popp1, Katharina Gerlach1, Stefanie Mott1

  • 1Department of Medicine, University of Erlangen-Nürnberg, Kussmaul Research Campus, Erlangen, Germany.

Gastroenterology
|September 19, 2016
PubMed
Summary

GATA3 is elevated in ulcerative colitis (UC) and drives inflammatory cytokine production. A GATA3-specific DNAzyme (hgd40) effectively reduced colitis in mice, suggesting potential for UC treatment.

Keywords:
DNA CleavageGene RegulationImmune ResponseMouse Model

More Related Videos

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

49.3K
Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
09:31

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model

Published on: November 9, 2018

9.2K

Related Experiment Videos

Last Updated: Mar 15, 2026

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
09:08

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

2.1K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

49.3K
Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
09:31

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model

Published on: November 9, 2018

9.2K

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • GATA3 is a key transcription factor regulating T-cell cytokine production.
  • Investigated the role of GATA3 in the development of colitis.
  • GATA3 expression is linked to inflammatory responses in T cells.

Purpose of the Study:

  • To determine the role of GATA3 in colitis development.
  • To assess the therapeutic potential of targeting GATA3 in ulcerative colitis (UC).
  • To evaluate a GATA3-specific DNAzyme (hgd40) for colitis treatment.

Main Methods:

  • Quantitative PCR and immunofluorescence on human and mouse colon tissues.
  • Induction of colitis in mice using oxazolone or TNBS, with genetic modifications (GATA3 deletion, TNFR knockout).
  • Administration of GATA3-specific DNAzyme (hgd40) or control DNAzyme, anti-TNF antibody, and in vivo imaging.

Main Results:

  • GATA3 mRNA levels were higher in UC patients' colon tissues and correlated with inflammatory cytokines.
  • T-cell-specific GATA3 deletion prevented colitis development in mice.
  • The DNAzyme hgd40 inhibited GATA3 expression, reduced colitis, and decreased inflammatory cytokine levels in mice.

Conclusions:

  • GATA3 levels are elevated in UC and correlate with inflammatory cytokine production.
  • A GATA3-targeting DNAzyme (hgd40) effectively reduced colitis in mouse models, independent of TNF signaling.
  • The GATA3-specific DNAzyme hgd40 shows promise as a novel therapeutic agent for ulcerative colitis.